Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

Dry Eye Etiology: Focus on Friction.

van Setten GB, Mueller-Lierheim W, Baudouin C.

Klin Monbl Augenheilkd. 2019 Jul 30. doi: 10.1055/a-0898-3857. [Epub ahead of print] No abstract available.

2.

Osmokinetics: A new dynamic concept in dry eye disease.

van Setten GB.

J Fr Ophtalmol. 2019 Mar;42(3):221-225. doi: 10.1016/j.jfo.2018.11.001. Epub 2019 Mar 7.

PMID:
30851972
3.

Reconsidering the central role of mucins in dry eye and ocular surface diseases.

Baudouin C, Rolando M, Benitez Del Castillo JM, Messmer EM, Figueiredo FC, Irkec M, Van Setten G, Labetoulle M.

Prog Retin Eye Res. 2019 Jul;71:68-87. doi: 10.1016/j.preteyeres.2018.11.007. Epub 2018 Nov 22. Review.

PMID:
30471351
4.

Author's Reply to: "Concerns Over: Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in the Treatment of Severe Dry Eye Disease".

Leonardi A, Van Setten G, Amrane M, Ismail D, Garrigue JS, Figueiredo FC, Baudouin C.

Eur J Ophthalmol. 2017 Nov 8;27(6):e194-e195. doi: 10.5301/ejo.5001043. No abstract available.

PMID:
28967083
5.

Clinical impact of inflammation in dry eye disease: proceedings of the ODISSEY group meeting.

Baudouin C, Irkeç M, Messmer EM, Benítez-Del-Castillo JM, Bonini S, Figueiredo FC, Geerling G, Labetoulle M, Lemp M, Rolando M, Van Setten G, Aragona P; ODISSEY European Consensus Group Members.

Acta Ophthalmol. 2018 Mar;96(2):111-119. doi: 10.1111/aos.13436. Epub 2017 Apr 8. Review.

6.

Pan-European survey of the topical ocular use of cyclosporine A.

Labbé A, Baudouin C, Ismail D, Amrane M, Garrigue JS, Leonardi A, Figueiredo FC, Van Setten G, Labetoulle M.

J Fr Ophtalmol. 2017 Mar;40(3):187-195. doi: 10.1016/j.jfo.2016.12.004. Epub 2017 Mar 17.

7.

Comparison of the performance and safety of 2 ophthalmic viscosurgical devices in cataract surgery.

Auffarth GU, Auerbach FN, Rabsilber T, Gegúndez JA, Cuiña R, Renard Y, Vinciguerra P, Camesasca F, Van Cauwenberge F, Amzallag T, Van Setten G, Holzer MP.

J Cataract Refract Surg. 2017 Jan;43(1):87-94. doi: 10.1016/j.jcrs.2016.10.025.

PMID:
28317684
8.

Patients' perception of DED and its relation with time to diagnosis and quality of life: an international and multilingual survey.

Labetoulle M, Rolando M, Baudouin C, van Setten G.

Br J Ophthalmol. 2017 Aug;101(8):1100-1105. doi: 10.1136/bjophthalmol-2016-309193. Epub 2016 Dec 21.

PMID:
28003235
9.

Immunohistochemical Detection of CTGF in the Human Eye.

van Setten GB, Trost A, Schrödl F, Kaser-Eichberger A, Bogner B, van Setten M, Heindl LM, Grabner G, Reitsamer HA.

Curr Eye Res. 2016 Dec;41(12):1571-1579. Epub 2016 Jun 23.

PMID:
27337054
10.

Evidence of seasonality and effects of psychrometry in dry eye disease.

van Setten G, Labetoulle M, Baudouin C, Rolando M.

Acta Ophthalmol. 2016 Aug;94(5):499-506. doi: 10.1111/aos.12985. Epub 2016 Apr 23.

11.

Efficacy and safety of 0.1% cyclosporine A cationic emulsion in the treatment of severe dry eye disease: a multicenter randomized trial.

Leonardi A, Van Setten G, Amrane M, Ismail D, Garrigue JS, Figueiredo FC, Baudouin C.

Eur J Ophthalmol. 2016 Jun 10;26(4):287-96. doi: 10.5301/ejo.5000779. Epub 2016 Apr 7.

PMID:
27055414
12.

Diagnosing the severity of dry eye: a clear and practical algorithm.

Baudouin C, Aragona P, Van Setten G, Rolando M, Irkeç M, Benítez del Castillo J, Geerling G, Labetoulle M, Bonini S; ODISSEY European Consensus Group members.

Br J Ophthalmol. 2014 Sep;98(9):1168-76. doi: 10.1136/bjophthalmol-2013-304619. Epub 2014 Mar 13.

13.

Increasing the safety of cataract surgery of hard lenses: phaco-on-top technique.

van Setten G.

J Cataract Refract Surg. 2010 Oct;36(10):1794-6. doi: 10.1016/j.jcrs.2010.08.023. No abstract available.

PMID:
20870131
14.

Bimanual implantation of the capsular tension ring: minimizing capsular stress, optimizing surgical outcome and efficacy.

van Setten G.

Acta Ophthalmol. 2009 Feb;87(1):107-9. doi: 10.1111/j.1600-0420.2007.01092.x. Epub 2008 Nov 18. No abstract available.

15.
16.

Dysfunctional tear syndrome: a Delphi approach to treatment recommendations.

Behrens A, Doyle JJ, Stern L, Chuck RS, McDonnell PJ, Azar DT, Dua HS, Hom M, Karpecki PM, Laibson PR, Lemp MA, Meisler DM, Del Castillo JM, O'Brien TP, Pflugfelder SC, Rolando M, Schein OD, Seitz B, Tseng SC, van Setten G, Wilson SE, Yiu SC; Dysfunctional tear syndrome study group.

Cornea. 2006 Sep;25(8):900-7.

PMID:
17102664
17.

Detection of PEDF in subretinal fluid of retinal detachment: possible role in the prevention of subretinal neovascularization. preliminary results.

Abdiu O, Olivestedt G, Berglin L, van Setten G.

Ophthalmic Res. 2006;38(4):189-92. Epub 2006 May 4.

PMID:
16679806
18.

The triple classification of dry eye for practical clinical use.

Murube J, Németh J, Höh H, Kaynak-Hekimhan P, Horwath-Winter J, Agarwal A, Baudouin C, Benítez del Castillo JM, Cervenka S, ChenZhuo L, Ducasse A, Durán J, Holly F, Javate R, Nepp J, Paulsen F, Rahimi A, Raus P, Shalaby O, Sieg P, Soriano H, Spinelli D, Ugurbas SH, Van Setten G.

Eur J Ophthalmol. 2005 Nov-Dec;15(6):660-7.

PMID:
16329048
19.

Detection of connective tissue growth factor in subretinal Fluid following retinal detachment: possible contribution to subretinal scar formation, preliminary results.

van Setten G, Berglin L, Blalock TD, Schultz G.

Ophthalmic Res. 2005 Nov-Dec;37(6):289-92. Epub 2005 Aug 22.

PMID:
16118511
20.

Profiles of matrix metalloproteinase activity in equine tear fluid during corneal healing in 10 horses with ulcerative keratitis.

Ollivier FJ, Brooks DE, Van Setten GB, Schultz GS, Gelatt KN, Stevens GR, Blalock TD, Andrew SE, Komaromy AM, Lassaline ME, Kallberg ME, Cutler TJ.

Vet Ophthalmol. 2004 Nov-Dec;7(6):397-405.

PMID:
15511281
21.

Basic fibroblast growth factor (bFGF) in saliva and oral mucosa in patients with oral lichen planus: preliminary observations.

Magnusson M, Pyykkö I, van Setten G, Norlander T, Nastri A, Westermark A.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 Sep;98(3):324-6.

PMID:
15356471
22.

The immediate approach anterior capsulorhexis (IAAC) in cataract surgery: contribution to safety and efficacy.

van Setten G, Al Ahmary AM.

Acta Ophthalmol Scand. 2003 Dec;81(6):661-2. No abstract available.

23.

Connective tissue growth factor in tear film of the horse: detection, identification and origin.

Ollivier FJ, Brooks DE, Schultz GS, Blalock TD, Andrew SE, Komaromy AM, Cutler TJ, Lassaline ME, Kallberg ME, Van Setten GB.

Graefes Arch Clin Exp Ophthalmol. 2004 Feb;242(2):165-171. doi: 10.1007/s00417-003-0802-x. Epub 2003 Nov 28.

PMID:
14648133
24.

Evaluation of various compounds to inhibit activity of matrix metalloproteinases in the tear film of horses with ulcerative keratitis.

Ollivier FJ, Brooks DE, Kallberg ME, Komaromy AM, Lassaline ME, Andrew SE, Gelatt KN, Stevens GR, Blalock TD, van Setten GB, Schultz GS.

Am J Vet Res. 2003 Sep;64(9):1081-7.

PMID:
13677383
25.

Detection of connective tissue growth factor (CTGF) in human tear fluid: preliminary results.

van Setten GB, Blalock TD, Grotendorst G, Schultz GS.

Acta Ophthalmol Scand. 2003 Feb;81(1):51-3.

26.

Immunodacryochemistry (immunoferning): a new screening method for proteins in tears.

van Setten G.

Adv Exp Med Biol. 2002;506(Pt A):611-5. No abstract available.

PMID:
12613968
27.

Connective tissue growth factor in pterygium: simultaneous presence with vascular endothelial growth factor - possible contributing factor to conjunctival scarring.

van Setten G, Aspiotis M, Blalock TD, Grotendorst G, Schultz G.

Graefes Arch Clin Exp Ophthalmol. 2003 Feb;241(2):135-9. Epub 2002 Dec 24.

PMID:
12605268
28.

Detection of connective tissue growth factor in human aqueous humor.

van Setten GB, Blalock TD, Grotendorst G, Schultz GS.

Ophthalmic Res. 2002 Sep-Oct;34(5):306-8.

PMID:
12381892
29.

Basic fibroblast growth factor in human saliva decreases with aging.

Westermark A, Pyykkö I, Magnusson M, Ishizaki H, Jäntti P, van Setten G.

Laryngoscope. 2002 May;112(5):887-9.

PMID:
12150623
30.

Elevated intraocular levels of insulin-like growth factor I in a diabetic patient with acromegaly.

van Setten G, Brismar K, Algvere P.

Orbit. 2002 Jun;21(2):161-7.

PMID:
12029573
31.

Cellular proliferation and leukocyte infiltration in the rabbit cornea after photorefractive keratectomy.

Gan L, Hamberg-Nyström H, Fagerholm P, Van Setten G.

Acta Ophthalmol Scand. 2001 Oct;79(5):488-92.

32.

Anterior lenticonus: histological evaluation and approach for cataract surgery.

van Setten G.

J Cataract Refract Surg. 2001 Jul;27(7):1071-5.

PMID:
11489578
33.

Basic fibroblast growth factor in nasal polyps immunohistochemical and quantitative findings.

Norlander T, Westermark A, van Setten G, Valtonen H, Ishizaki H, Pyykkö I.

Rhinology. 2001 Jun;39(2):88-92.

PMID:
11486445
34.

Enhanced short-term plasmid transfection of filtration surgery tissues.

Angella GJ, Sherwood MB, Balasubramanian L, Doyle JW, Smith MF, van Setten G, Goldstein M, Schultz GS.

Invest Ophthalmol Vis Sci. 2000 Dec;41(13):4158-62.

PMID:
11095609
35.

Basic fibroblast growth factor (bFGF) in saliva--physiological and clinical implications.

Ishizaki H, Westermark A, van Setten G, Pyykkö I.

Acta Otolaryngol Suppl. 2000;543:193-5.

PMID:
10909018
36.

Levels of transforming growth factor alpha (TGF-alpha) in human cerebrospinal fluid.

Van Setten GB, Edström L, Stibler H, Rasmussen S, Schultz G.

Int J Dev Neurosci. 1999 Apr;17(2):131-4.

PMID:
10221672
37.
39.

Dry eye syndrome, tear film, pharmacology of eye drops, and toxicity.

van Setten GB.

Curr Opin Ophthalmol. 1997 Aug;8(4):41-5. Review.

PMID:
10170443
40.

Comparison of corneal epithelial wound healing after photorefractive keratectomy in the rabbit with two types of excimer lasers.

Hamberg-Nyström H, van Setten GB, Fagerholm P.

J Refract Surg. 1997 May-Jun;13(3):263-7.

PMID:
9183758
41.

Beta-amyloid protein protein precursor expression in lacrimal glands and tear fluid.

Van Setten GB, Nilsson L, Hahne S, Johnston JA, Kvanta A, Gandy SE, Näslund J, Nordstedt C.

Invest Ophthalmol Vis Sci. 1996 Dec;37(13):2585-93.

PMID:
8977472
42.

The clinical use of contact lenses and collagen shields.

van Setten GB.

Curr Opin Ophthalmol. 1996 Aug;7(4):17-21. Review.

PMID:
10163633
43.

Basic fibroblast growth factor in human tear fluid: detection of another growth factor.

van Setten GB.

Graefes Arch Clin Exp Ophthalmol. 1996 Apr;234(4):275-7.

PMID:
8964535
44.
45.

Inhibition of pseudomonal ulceration in rabbit corneas by a synthetic matrix metalloproteinase inhibitor.

Barletta JP, Angella G, Balch KC, Dimova HG, Stern GA, Moser MT, van Setten GB, Schultz GS.

Invest Ophthalmol Vis Sci. 1996 Jan;37(1):20-8.

PMID:
8550324
46.

Detection of transforming growth factor-alpha mRNA and protein in rat lacrimal glands and characterization of transforming growth factor-alpha in human tears.

van Setten GB, Macauley S, Humphreys-Beher M, Chegini N, Schultz G.

Invest Ophthalmol Vis Sci. 1996 Jan;37(1):166-73.

PMID:
8550319
47.

Proliferating cell nuclear antigen colocalization with corneal epithelial stem cells and involvement in physiological cell turnover.

Gan L, van Setten G, Seregard S, Fagerholm P.

Acta Ophthalmol Scand. 1995 Dec;73(6):491-5.

PMID:
9019370
48.

Proliferating cell nuclear antigen: contradictory results regarding its presence in the lens.

Gan L, van Setten G, Fagerholm P.

Graefes Arch Clin Exp Ophthalmol. 1995 Dec;233(12):792-4.

PMID:
8626089
49.
50.

Presence of basic fibroblast growth factor in corneal epithelium.

van Setten G, Fagerholm P, Cuevas-Sanchez P.

Ophthalmic Res. 1995;27(6):317-21.

PMID:
8927303

Supplemental Content

Loading ...
Support Center